New knee pain drug CX-011 enters human trials
NCT ID NCT07308834
First seen Jan 05, 2026 · Last updated May 20, 2026 · Updated 18 times
Summary
This early-stage study tests a drug called CX-011 for people with moderate to severe knee osteoarthritis pain. The main goal is to see if the drug is safe and tolerable when injected into the knee joint. Researchers will also check if it helps reduce pain and improve knee function over 24 weeks. About 72 adults aged 18 to 75 with knee osteoarthritis will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS OF THE KNEES are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.